Diligence memo · auto-generated · as of July 2, 2026
Group K Diagnostics, Inc.
Group K Diagnostics, Inc. looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Group K Diagnostics, Inc. operates in Medical Devices, based in PHILADELPHIA.
Sub-sector tags: medical-devices.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Group K Diagnostics, Inc. has raised $6.5M in disclosed capital across 4 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $4.5M on 2018-10-04.
Most recent recorded round closed around 2020-07-24.
Valuation (modeled)modeled
Provath models Group K Diagnostics, Inc. at approximately $15M (range $804K–$83M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.31× the median modeled value of Series A Medical Devices companies in 2019–2021 (17 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 8 months.
Last raise 5.9 yr ago; this sector typically re-raises about every 16 months.
Silent for over 3× the sector's normal cadence.
The last round was 1.5× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 73% of Medical Devices peers (233 compared).
Modeled value ranks above 57% of those peers.
Closest niche peers: Reliant Immune Diagnostics, Inc., Pristine Surgical LLC, Predictive Health Diagnostics Co., Juno Diagnostics, Inc., Allotrope Medical Inc..
Peoplefiled
3 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.